Pharmatis-Sas
bd_17172e6ca6a6fd68 · schema v1 · pii pii-v1
Full breach record for Pharmatis-Sas →Threat-actor claim — not a regulatory filing
This row is a claim by the ransomware group INC Ransom on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Source: Ransomware.live
Post text · scraped from the leak site
Pharmatis is, as always, a company on a human scale, with multidiscipline, responsive teams that listen to their customers. It provides a local relationship, with advice on technical matters and regulations and personalised support for the creation or development of product ranges, offering full-service solutions. Pharmatis has a dedicated CSR policy, paying particular attention to impact on the environment and quality of life at work. In 1998, it was the first pharmaceutical company to be awarded ISO 14 001 certification. Expertise, exacting standards, transparency, integrity, respect and flexibility form the basis of all collaboration.
Source provenance
- Source URL
- https://www.ransomware.live/
DisclosureLens links to the originating regulator URL — full filing bodies are not redistributed from public surfaces (§4.5).
- Filed at
- Nov 15, 2024
- Raw hash
- a7cf248bdd5e7000305879171ad2869ee072ab128e537c38aa41842c2352c069
Reporting entity
- Name
- incransomnorm: inc_ransom
Victim entity
- Name
- Pharmatis-Sasnorm: pharmatis sas
- Domain
- pharmatis.com
- Industry
- Healthcare
What this source establishes
- Source ceiling
- A leak-site claim can't tell us: discovery date · materiality · notification · affected count · confirmed data types · compliance clock. These stay blank until a regulatory filing or victim disclosure lands.
- Attack vector
- Ransomware· inc_ransom
- Threat actor
- Inc RansomExternalFinancial
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.